{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:19:40Z","timestamp":1788445180781,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41596-025-01325-7","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:56:39Z","timestamp":1773158199000},"page":"3967-3995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preparation of placenta-tropic mRNA lipid nanoparticles for pregnancy disorders"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-9206","authenticated-orcid":false,"given":"Kelsey L.","family":"Swingle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","volume":"5","author":"AM Vargason","year":"2021","unstructured":"Vargason, A. M., Anselmo, A. C. & Mitragotri, S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 5, 951\u2013967 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"1325_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","volume":"27","author":"KL Swingle","year":"2021","unstructured":"Swingle, K. L., Hamilton, A. G. & Mitchell, M. J. Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines. Trends Mol. Med. 27, 616\u2013617 (2021).","journal-title":"Trends Mol. Med."},{"key":"1325_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"R Baden Lindsey","year":"2021","unstructured":"Baden Lindsey, R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1325_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"P Polack Fernando","year":"2020","unstructured":"Polack Fernando, P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1325_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa2412309","volume":"391","author":"M Fontana","year":"2024","unstructured":"Fontana, M. et al. CRISPR-Cas9 gene editing with nexiguran ziclumeran for ATTR cardiomyopathy. N. Engl. J. Med. 391, 2231\u20132241 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1325_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","volume":"23","author":"PR Cullis","year":"2024","unstructured":"Cullis, P. R. & Felgner, P. L. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat. Rev. Drug Discov. 23, 709\u2013722 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1325_CR7","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0910603106","volume":"107","author":"KT Love","year":"2010","unstructured":"Love, K. T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. USA 107, 1864\u20131869 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1325_CR8","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1021\/acs.nanolett.0c00596","volume":"20","author":"KA Hajj","year":"2020","unstructured":"Hajj, K. A. et al. A potent branched-tail lipid nanoparticle enables multiplexed mRNA delivery and gene editing in vivo. Nano Lett. 20, 5167\u20135175 (2020).","journal-title":"Nano Lett."},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."},{"key":"1325_CR10","doi-asserted-by":"publisher","first-page":"e2312026","DOI":"10.1002\/adma.202312026","volume":"36","author":"S Omo-Lamai","year":"2024","unstructured":"Omo-Lamai, S. et al. Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions. Adv. Mater. 36, e2312026 (2024).","journal-title":"Adv. Mater."},{"key":"1325_CR11","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1021\/jacs.2c02706","volume":"144","author":"L Xue","year":"2022","unstructured":"Xue, L. et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J. Am. Chem. Soc. 144, 9926\u20139937 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"1325_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1444","volume":"9","author":"JR Melamed","year":"2023","unstructured":"Melamed, J. R. et al. Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer. Sci. Adv. 9, eade1444 (2023).","journal-title":"Sci. Adv."},{"key":"1325_CR13","doi-asserted-by":"publisher","first-page":"e2304378","DOI":"10.1002\/smll.202304378","volume":"20","author":"MM Billingsley","year":"2024","unstructured":"Billingsley, M. M. et al. In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism. Small 20, e2304378 (2024).","journal-title":"Small"},{"key":"1325_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"1325_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32281-5","volume":"13","author":"H Ni","year":"2022","unstructured":"Ni, H. et al. Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. Nat. Commun. 13, 4766 (2022).","journal-title":"Nat. Commun."},{"key":"1325_CR16","doi-asserted-by":"publisher","first-page":"e2400783121","DOI":"10.1073\/pnas.2400783121","volume":"121","author":"R Palanki","year":"2024","unstructured":"Palanki, R. et al. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Proc. Natl Acad. Sci. USA 121, e2400783121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1325_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"1325_CR18","doi-asserted-by":"crossref","unstructured":"Funding research on women\u2019s health. Nat. Rev. Bioeng. 2, 797\u2013798 (2024).","DOI":"10.1038\/s44222-024-00253-7"},{"key":"1325_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/d43747-024-00021-x","author":"K Moley","year":"2024","unstructured":"Moley, K. Closing the gender health gap is a $1 trillion opportunity. Biopharm. Deal. https:\/\/doi.org\/10.1038\/d43747-024-00021-x (2024).","journal-title":"Biopharm. Deal."},{"key":"1325_CR20","doi-asserted-by":"crossref","unstructured":"It\u2019s about time to focus on women\u2019s health. Nat. Rev. Bioeng. 1, 379 (2023).","DOI":"10.1038\/s44222-023-00081-1"},{"key":"1325_CR21","doi-asserted-by":"crossref","unstructured":"Bilinski, A. & Emanuel, N. Fewer than 1% of United States clinical drug trials enroll pregnant participants. Am. J. Obstet. Gynecol. 232, e136\u2013e139 (2025).","DOI":"10.1016\/j.ajog.2024.12.028"},{"key":"1325_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30052-w","volume":"13","author":"S Prasad","year":"2022","unstructured":"Prasad, S. et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat. Commun. 13, 2414 (2022).","journal-title":"Nat. Commun."},{"key":"1325_CR23","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","volume":"384","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro, T. T. et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N. Engl. J. Med. 384, 2273\u20132282 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1325_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","volume":"27","author":"N Dagan","year":"2021","unstructured":"Dagan, N. et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat. Med. 27, 1693\u20131695 (2021).","journal-title":"Nat. Med."},{"key":"1325_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147553","volume":"131","author":"SL Klein","year":"2021","unstructured":"Klein, S. L., Creisher, P. S. & Burd, I. COVID-19 vaccine testing in pregnant females is necessary. J. Clin. Invest. 131, e147553 (2021).","journal-title":"J. Clin. Invest."},{"key":"1325_CR26","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1021\/jacs.2c12893","volume":"145","author":"KL Swingle","year":"2023","unstructured":"Swingle, K. L. et al. Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy. J. Am. Chem. Soc. 145, 4691\u20134706 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"1325_CR27","doi-asserted-by":"publisher","first-page":"2303568","DOI":"10.1002\/smll.202303568","volume":"20","author":"HC Safford","year":"2023","unstructured":"Safford, H. C. et al. Orthogonal design of experiments for engineering of lipid nanoparticles for mRNA delivery to the placenta. Small 20, 2303568 (2023).","journal-title":"Small"},{"key":"1325_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","volume":"371","author":"HC Geisler","year":"2024","unstructured":"Geisler, H. C. et al. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta. J. Control. Release 371, 455\u2013469 (2024).","journal-title":"J. Control. Release"},{"key":"1325_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","volume":"637","author":"KL Swingle","year":"2025","unstructured":"Swingle, K. L. et al. Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia. Nature 637, 412\u2013421 (2025).","journal-title":"Nature"},{"key":"1325_CR30","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1021\/acs.nanolett.4c06241","volume":"25","author":"HC Safford","year":"2025","unstructured":"Safford, H. C. et al. Probing the role of lipid nanoparticle elasticity on mRNA delivery to the placenta. Nano Lett. 25, 4800\u20134808 (2025).","journal-title":"Nano Lett."},{"key":"1325_CR31","first-page":"125","volume":"34","author":"RE Young","year":"2024","unstructured":"Young, R. E. et al. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach. Bioact. Mater. 34, 125\u2013137 (2024).","journal-title":"Bioact. Mater."},{"key":"1325_CR32","doi-asserted-by":"publisher","first-page":"e2307810121","DOI":"10.1073\/pnas.2307810121","volume":"121","author":"N Chaudhary","year":"2024","unstructured":"Chaudhary, N. et al. Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. Proc. Natl Acad. Sci. USA 121, e2307810121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1325_CR33","doi-asserted-by":"publisher","first-page":"e00148","DOI":"10.1002\/adtp.202500148","volume":"8","author":"SI Hofbauer","year":"2025","unstructured":"Hofbauer, S. I. et al. Cytokine mRNA delivery and local immunomodulation in the placenta using lipid nanoparticles. Adv. Ther. 8, e00148 (2025).","journal-title":"Adv. Ther."},{"key":"1325_CR34","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. Engl. 51, 8529\u20138533 (2012).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1325_CR35","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","volume":"31","author":"V Francia","year":"2020","unstructured":"Francia, V., Schiffelers, R. M., Cullis, P. R. & Witzigmann, D. The biomolecular corona of lipid nanoparticles for gene therapy. Bioconjug. Chem. 31, 2046\u20132059 (2020).","journal-title":"Bioconjug. Chem."},{"key":"1325_CR36","doi-asserted-by":"publisher","first-page":"e2109256118","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1325_CR37","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1039\/D2LC00799A","volume":"23","author":"G Bashiri","year":"2023","unstructured":"Bashiri, G. et al. Nanoparticle protein corona: from structure and function to therapeutic targeting. Lab Chip 23, 1432\u20131466 (2023).","journal-title":"Lab Chip"},{"key":"1325_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341\u2013354 (2021).","journal-title":"Lancet"},{"key":"1325_CR39","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nbt.4297","volume":"36","author":"AA Turanov","year":"2018","unstructured":"Turanov, A. A. et al. RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nat. Biotechnol. 36, 1164\u20131173 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1325_CR40","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang, R. et al. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomater. Sci. 9, 1449\u20131463 (2021).","journal-title":"Biomater. Sci."},{"key":"1325_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63726-2","volume":"16","author":"E Voke","year":"2025","unstructured":"Voke, E. et al. Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo. Nat. Commun. 16, 8699 (2025).","journal-title":"Nat. Commun."},{"key":"1325_CR42","doi-asserted-by":"publisher","first-page":"e1600349","DOI":"10.1126\/sciadv.1600349","volume":"2","author":"A King","year":"2016","unstructured":"King, A. et al. Tumor-homing peptides as tools for targeted delivery of payloads to the placenta. Sci. Adv. 2, e1600349 (2016).","journal-title":"Sci. Adv."},{"key":"1325_CR43","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.7150\/thno.22904","volume":"8","author":"B Zhang","year":"2018","unstructured":"Zhang, B. et al. Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice. Theranostics 8, 2765\u20132781 (2018).","journal-title":"Theranostics"},{"key":"1325_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fbioe.2020.00064","volume":"8","author":"L Li","year":"2020","unstructured":"Li, L. et al. Trophoblast-targeted nanomedicine modulates placental sFLT1 for preeclampsia treatment. Front. Bioeng. Biotechnol. 8, 64 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1325_CR45","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.7150\/thno.19678","volume":"7","author":"N Cureton","year":"2017","unstructured":"Cureton, N. et al. Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired uteroplacental perfusion in pregnancy. Theranostics 7, 3715\u20133731 (2017).","journal-title":"Theranostics"},{"key":"1325_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2020.05.033","volume":"324","author":"AA Alfaifi","year":"2020","unstructured":"Alfaifi, A. A. et al. Megalin-targeting liposomes for placental drug delivery. J. Control. Release 324, 366\u2013378 (2020).","journal-title":"J. Control. Release"},{"key":"1325_CR47","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/pharmaceutics13111778","volume":"13","author":"LJ Renshall","year":"2021","unstructured":"Renshall, L. J. et al. Targeted delivery of epidermal growth factor to the human placenta to treat fetal growth restriction. Pharmaceutics 13, 1778 (2021).","journal-title":"Pharmaceutics"},{"key":"1325_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2020.02.006","volume":"93","author":"RL Wilson","year":"2020","unstructured":"Wilson, R. L. et al. Nanoparticle mediated increased insulin-like growth factor 1 expression enhances human placenta syncytium function. Placenta 93, 1\u20137 (2020).","journal-title":"Placenta"},{"key":"1325_CR49","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/acsbiomaterials.0c00826","volume":"6","author":"L Li","year":"2020","unstructured":"Li, L. et al. Nanoparticle-mediated simultaneous downregulation of placental Nrf2 and sFlt1 improves maternal and fetal outcomes in a preeclampsia mouse model. ACS Biomater. Sci. Eng. 6, 5866\u20135873 (2020).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"1325_CR50","doi-asserted-by":"publisher","first-page":"102412","DOI":"10.1016\/j.nano.2021.102412","volume":"36","author":"NS Irvin-Choy","year":"2021","unstructured":"Irvin-Choy, N. S., Nelson, K. M., Dang, M. N., Gleghorn, J. P. & Day, E. S. Gold nanoparticle biodistribution in pregnant mice following intravenous administration varies with gestational age. Nanomedicine 36, 102412 (2021).","journal-title":"Nanomedicine"},{"key":"1325_CR51","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1038\/s41596-024-01134-4","volume":"20","author":"Y Ma","year":"2025","unstructured":"Ma, Y., VanKeulen-Miller, R. & Fenton, O. S. mRNA lipid nanoparticle formulation, characterization and evaluation. Nat. Protoc. 20, 2618\u20132651 (2025).","journal-title":"Nat. Protoc."},{"key":"1325_CR52","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s44222-023-00040-w","volume":"1","author":"KL Swingle","year":"2023","unstructured":"Swingle, K. L., Ricciardi, A. S., Peranteau, W. H. & Mitchell, M. J. Delivery technologies for women\u2019s health applications. Nat. Rev. Bioeng. 1, 408\u2013425 (2023).","journal-title":"Nat. Rev. Bioeng."},{"key":"1325_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1293\/tox.2013-0060","volume":"27","author":"S Furukawa","year":"2014","unstructured":"Furukawa, S., Kuroda, Y. & Sugiyama, A. A comparison of the histological structure of the placenta in experimental animals. J. Toxicol. Pathol. 27, 11\u201318 (2014).","journal-title":"J. Toxicol. Pathol."},{"key":"1325_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).","journal-title":"Nat. Commun."},{"key":"1325_CR55","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","volume":"23","author":"B Li","year":"2024","unstructured":"Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002\u20131008 (2024).","journal-title":"Nat. Mater."},{"key":"1325_CR56","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","volume":"20","author":"MM Billingsley","year":"2020","unstructured":"Billingsley, M. M. et al. Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering. Nano Lett. 20, 1578\u20131589 (2020).","journal-title":"Nano Lett."},{"key":"1325_CR57","doi-asserted-by":"publisher","unstructured":"Han, X. et al. Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.25.640222 (2025).","DOI":"10.1101\/2025.02.25.640222"},{"key":"1325_CR58","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1325_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55137-6","volume":"16","author":"MS Padilla","year":"2025","unstructured":"Padilla, M. S. et al. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering. Nat. Commun. 16, 996 (2025).","journal-title":"Nat. Commun."},{"key":"1325_CR60","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300\u20137306 (2015).","journal-title":"Nano Lett."},{"key":"1325_CR61","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357\u20131364 (2010).","journal-title":"Mol. Ther."},{"key":"1325_CR62","doi-asserted-by":"publisher","first-page":"100610","DOI":"10.1016\/j.blre.2019.100610","volume":"39","author":"T McDonnell","year":"2020","unstructured":"McDonnell, T. et al. The role of beta-2-glycoprotein I in health and disease associating structure with function: more than just APS. Blood Rev. 39, 100610 (2020).","journal-title":"Blood Rev."},{"key":"1325_CR63","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/ard.2004.021444","volume":"64","author":"S Di","year":"2005","unstructured":"Di, S. et al. Pathogenic role of anti-\u00df2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of \u00df2-glycoprotein I binding to trophoblast cells and functional effects of anti-\u00df2-glycoprotein I antibodies in vitro. Ann. Rheum. Dis. 64, 462\u2013467 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"1325_CR64","doi-asserted-by":"publisher","first-page":"eaba0310","DOI":"10.1126\/sciadv.aba0310","volume":"6","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. TMEM16F phospholipid scramblase mediates trophoblast fusion and placental development. Sci. Adv. 6, eaba0310 (2020).","journal-title":"Sci. Adv."},{"key":"1325_CR65","doi-asserted-by":"publisher","first-page":"e81273","DOI":"10.1371\/journal.pone.0081273","volume":"8","author":"MR Riddell","year":"2013","unstructured":"Riddell, M. R., Winkler-Lowen, B., Jiang, Y., Davidge, S. T. & Guilbert, L. J. Pleiotropic actions of forskolin result in phosphatidylserine exposure in primary trophoblasts. PLoS One 8, e81273 (2013).","journal-title":"PLoS One"},{"key":"1325_CR66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0143-4004(97)80040-9","volume":"18","author":"LW Chamley","year":"1997","unstructured":"Chamley, L. W., Allen, J. L. & Johnson, P. M. Synthesis of \u03b22 glycoprotein 1 by the human placenta. Placenta 18, 403\u2013410 (1997).","journal-title":"Placenta"},{"key":"1325_CR67","volume":"2012","author":"KA Pennington","year":"2012","unstructured":"Pennington, K. A., Schlitt, J. M. & Schulz, L. C. Isolation of primary mouse trophoblast cells and trophoblast invasion assay. J. Vis. Exp. 2012, e3202 (2012).","journal-title":"J. Vis. Exp."},{"key":"1325_CR68","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.placenta.2024.08.007","volume":"166","author":"KL Swingle","year":"2024","unstructured":"Swingle, K. L., Hamilton, A. G. & Mitchell, M. J. Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy. Placenta 166, 132\u2013138 (2024).","journal-title":"Placenta"},{"key":"1325_CR69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0014-4827(90)90310-7","volume":"186","author":"B Wice","year":"1990","unstructured":"Wice, B., Menton, D., Geuze, H. & Schwartz, A. L. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp. Cell Res. 186, 306\u2013316 (1990).","journal-title":"Exp. Cell Res."},{"key":"1325_CR70","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","volume":"21","author":"SJ Shepherd","year":"2021","unstructured":"Shepherd, S. J. et al. Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device. Nano Lett. 21, 5671\u20135680 (2021).","journal-title":"Nano Lett."},{"key":"1325_CR71","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"1325_CR72","doi-asserted-by":"publisher","first-page":"2300852","DOI":"10.1002\/smll.202300852","volume":"20","author":"HC Geisler","year":"2023","unstructured":"Geisler, H. C., Safford, H. C. & Mitchell, M. J. Rational design of nanomedicine for placental disorders: birthing a new era in women\u2019s reproductive health. Small 20, 2300852 (2023).","journal-title":"Small"}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01325-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:02:26Z","timestamp":1788444146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41596-025-01325-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1038\/s41596-025-01325-7","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L.S. and M.J.M. have filed a patent application based on this work. M.J.M. is an inventor on a patent related to this work filed by the Trustees of the University of Pennsylvania.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}